Histopathological vertical margin positivity in cold snare polypectomy and mucosal resection for sessile serrated lesions.

Cold snare polypectomy Colorectal polyp Endoscopic mucosal resection Sessile serrated lesion

Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
23 Jan 2024
Historique:
received: 18 07 2023
revised: 28 12 2023
accepted: 16 01 2024
medline: 26 1 2024
pubmed: 26 1 2024
entrez: 25 1 2024
Statut: aheadofprint

Résumé

Evidence regarding the status of the vertical margin of sessile serrated lesions (SSLs) resected using cold snare polypectomy (CSP) is lacking, and whether a histopathologically positive vertical margin is related to recurrence remains unclear. Therefore, this preliminary study aimed to clarify the rates of positive or unevaluable vertical and horizontal margins and the rate of muscularis mucosae resection in SSLs treated using CSP compared with those treated with endoscopic mucosal resection (EMR). Histological outcomes of patients treated with CSP or EMR for SSL were evaluated in this single-center observational study. The primary outcome was the incidence of histopathologically positive vertical margins in CSP and EMR. Furthermore, the comparisons were adjusted for confounding factors using propensity score matching. Overall, 82 patients with SSLs were included in the CSP and EMR groups after matching. The incidence of positive histological vertical margins in the CSP and EMR groups were 67.1% and 2.4%, respectively (p<0.001). Regarding the evaluation of the presence of muscularis mucosae, 29.3% and 98.8% of the patients in the CSP and EMR groups, respectively, had a complete muscularis mucosae resection (p<0.001). A rigorous histopathologic evaluation revealed that for SSLs, CSP more frequently leads to positive vertical margins than EMR.

Sections du résumé

BACKGROUND AND AIMS OBJECTIVE
Evidence regarding the status of the vertical margin of sessile serrated lesions (SSLs) resected using cold snare polypectomy (CSP) is lacking, and whether a histopathologically positive vertical margin is related to recurrence remains unclear. Therefore, this preliminary study aimed to clarify the rates of positive or unevaluable vertical and horizontal margins and the rate of muscularis mucosae resection in SSLs treated using CSP compared with those treated with endoscopic mucosal resection (EMR).
METHODS METHODS
Histological outcomes of patients treated with CSP or EMR for SSL were evaluated in this single-center observational study. The primary outcome was the incidence of histopathologically positive vertical margins in CSP and EMR. Furthermore, the comparisons were adjusted for confounding factors using propensity score matching.
RESULTS RESULTS
Overall, 82 patients with SSLs were included in the CSP and EMR groups after matching. The incidence of positive histological vertical margins in the CSP and EMR groups were 67.1% and 2.4%, respectively (p<0.001). Regarding the evaluation of the presence of muscularis mucosae, 29.3% and 98.8% of the patients in the CSP and EMR groups, respectively, had a complete muscularis mucosae resection (p<0.001).
CONCLUSIONS CONCLUSIONS
A rigorous histopathologic evaluation revealed that for SSLs, CSP more frequently leads to positive vertical margins than EMR.

Identifiants

pubmed: 38272275
pii: S0016-5107(24)00044-0
doi: 10.1016/j.gie.2024.01.029
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc. All rights reserved.

Auteurs

Koichi Hamada (K)

Department of Gastroenterology, Southern-Tohoku General Hospital, Koriyama, Japan; Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan. Electronic address: koichi.hamada@mt.strins.or.jp.

Michitaka Honda (M)

Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan; Department of Surgery, Southern-Tohoku General Hospital, Koriyama, Japan.

Yoshinori Horikawa (Y)

Department of Gastroenterology, Southern-Tohoku General Hospital, Koriyama, Japan.

Yoshiki Shiwa (Y)

Department of Gastroenterology, Southern-Tohoku General Hospital, Koriyama, Japan.

Kae Techigawara (K)

Department of Gastroenterology, Southern-Tohoku General Hospital, Koriyama, Japan; Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan.

Takayuki Nagahashi (T)

Department of Gastroenterology, Southern-Tohoku General Hospital, Koriyama, Japan; Department of Minimally Invasive Surgical and Medical Oncology, Fukushima Medical University, Fukushima, Japan.

Masafumi Ishikawa (M)

Department of Gastroenterology, Southern-Tohoku General Hospital, Koriyama, Japan.

Yuki Takeda (Y)

Department of Gastroenterology, Southern-Tohoku General Hospital, Koriyama, Japan.

Daizo Fukushima (D)

Department of Gastroenterology, Southern-Tohoku General Hospital, Koriyama, Japan.

Noriyuki Nishino (N)

Department of Gastroenterology, Southern-Tohoku General Hospital, Koriyama, Japan.

Noriyuki Uesugi (N)

Department of Pahology, Southern-Tohoku General Hospital, Koriyama, Japan.

Masamichi Suzuki (M)

Department of Pahology, Southern-Tohoku General Hospital, Koriyama, Japan.

Tamotsu Sugai (T)

Department of Pahology, Southern-Tohoku General Hospital, Koriyama, Japan.

Classifications MeSH